CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Option exercise Director acquired 20,100 shares (option exercise)
- 8-K Event Regulation FD disclosure · Other events
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Agreement ended
- 4 Grant or award SVP, CFO, CBO & Treasurer acquired 350,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 30,000 shares (grant or award)
Page 6 of 45 · 886 filings